Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Safety of KSP Heptapeptide (KSP-910638G) in Humans for the Early Detection of GI Malignancies

NCT03161418 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT03161418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03161418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Safety of KSP Heptapeptide (KSP-910638G) in Humans for the Early Detection of GI Malignancies
Lead sponsor
University of Michigan
Phase
Phase 1
Overall status
Completed
Start date
June 21, 2017
Completion date
September 20, 2017
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adults